Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12

被引:72
作者
Takeda, K [1 ]
Hayakawa, Y
Atsuta, M
Hong, S
Van Kaer, L
Kobayashi, K
Ito, M
Yagita, H
Okumura, K
机构
[1] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Japan Sci & Technol Corp, CREST, Chiyoda Ku, Tokyo 1010062, Japan
[3] Toyama Med & Pharmaceut Univ, Res Inst Wakan Yaku, Dept Pathogen Biochem, Toyama 9300194, Japan
[4] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Howard Hughes Med Inst, Nashville, TN 37232 USA
[5] Cent Inst Expt Anim, Kawasaki, Kanagawa 2160001, Japan
关键词
anti-metastatic activity; IL-12; NK cell; NKT cell;
D O I
10.1093/intimm/12.6.909
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Conventional T cells, NK cells and NKT cells have been implicated in the anti-tumor activities induced by IL-12, Here we show that IL-12-induced immune responses are partially impaired in T and NKT cell-deficient RAG-2(-/-) mice, and in NKT cell-deficient CD1(-/-) mice. In response to a small dose (<1000 U) of IL-12, RAG-2(-/-) and CD1-/- mice demonstrated reduced cytotoxicity, serum IFN-gamma elevation and anti-metastatic activities; in contrast, in response to a high dose (>2000U) of IL-12, the IL-12-induced immune responses of RAG-2(-/-) and CD1(-/-) mice were indistinguishable from wildtype mice. The defective responses to low-dose IL-12 of RAG-2(-/-) mice were corrected by adoptive transfer of NKT cells but not NK cells. These findings indicate that both NK and NKT cells contribute to the anti-metastatic responses induced by IL-12, and that NKT cells are mostly responsible for the low-dose activities of this cytokine.
引用
收藏
页码:909 / 914
页数:6
相关论文
共 26 条
[1]   Mouse CD1-specific NK1 T cells: Development, specificity, and function [J].
Bendelac, A ;
Rivera, MN ;
Park, SH ;
Roark, JH .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :535-562
[2]  
BRUNDA MJ, 1994, J LEUKOCYTE BIOL, V55, P280
[3]   ANTITUMOR AND ANTIMETASTATIC ACTIVITY OF INTERLEUKIN-12 AGAINST MURINE TUMORS [J].
BRUNDA, MJ ;
LUISTRO, L ;
WARRIER, RR ;
WRIGHT, RB ;
HUBBARD, BR ;
MURPHY, M ;
WOLF, SF ;
GATELY, MK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (04) :1223-1230
[4]   Impaired NK1(+) T cell development and early IL-4 production in CD1-deficient mice [J].
Chen, YH ;
Chiu, NM ;
Mandal, M ;
Wang, N ;
Wang, CR .
IMMUNITY, 1997, 6 (04) :459-467
[5]   Requirement for V(alpha)14 NKT cells in IL-12-mediated rejection of tumors [J].
Cui, JQ ;
Shin, T ;
Kawano, T ;
Sato, H ;
Kondo, E ;
Toura, I ;
Kaneko, Y ;
Koseki, H ;
Kanno, M ;
Taniguchi, M .
SCIENCE, 1997, 278 (5343) :1623-1626
[6]  
HASHIMOTO W, 1995, J IMMUNOL, V154, P4333
[7]  
Kawagoshi Y, 1998, WORLD J MICROB BIOT, V14, P95
[8]  
Kawamura T, 1998, J IMMUNOL, V160, P16
[9]   CD1d-restricted and TCR-mediated activation of V(alpha)14 NKT cells by glycosylceramides [J].
Kawano, T ;
Cui, JQ ;
Koezuka, Y ;
Toura, I ;
Kaneko, Y ;
Motoki, K ;
Ueno, H ;
Nakagawa, R ;
Sato, H ;
Kondo, E ;
Koseki, H ;
Taniguchi, M .
SCIENCE, 1997, 278 (5343) :1626-1629
[10]   The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells [J].
Kitamura, H ;
Iwakabe, K ;
Yahata, T ;
Nishimura, S ;
Ohta, A ;
Ohmi, Y ;
Sato, M ;
Takeda, K ;
Okumura, K ;
van Kaer, L ;
Kawano, T ;
Taniguchi, M ;
Nishimura, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07) :1121-1127